Teva drug reduces MS relapses by 75 pct in study
Reuters via Yahoo! News Mon, 19 Jun 2006 11:11 AM PDT
Teva Pharmaceutical Industries Ltd's multiple sclerosis (MS) drug Copaxone reduced relapses by 75 percent in both new patients and those who had not done well on the older Schering AG medicine Betaseron, according to a large study.

Central Nervous System Beckons Attack In MS-like Disease Science Daily Sun, 18 Jun 2006 9:11 PM PDT It may sound like a case of blame the victim, but researchers at Washington University School of Medicine in St. Louis have shown that cells in the central nervous system can sometimes send out signals that invite hostile immune system attacks. In mice the researchers studied, this invitation resulted in damage to the protective covering of nerves, causing a disease resembling multiple sclerosis.

PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA RedNova Mon, 19 Jun 2006 6:04 AM PDT Additional Proposals Approved by Shareholders I

The Immune Response Corporation Completes First Stage of Enrollment and Receives Approval for Expansion of Phase II FinanzNachrichten Mon, 19 Jun 2006 6:18 AM PDT The Immune Response ( Nachrichten ) Corporation (OTCBB:IMNR) announced today the completion of the first stage of enrollment of drug-naive HIV patients in a Phase II clinical study being conducted in Italy.

Stem Cells Found In Adult Skin Can Be Transplanted And Function In Mouse Models Of Disease Medical News Today Mon, 19 Jun 2006 2:04 AM PDT Researchers at The Hospital for Sick Children (SickKids) and the University of Calgary have found that stem cells derived from adult skin can create neural cell types that can be transplanted into and function in mouse models of disease. This research is reported in the June 14, 2006 issue of The Journal of Neuroscience. [click link for full article]

The best medicine Colorado Springs Gazette Mon, 19 Jun 2006 0:16 AM PDT It didn’t take John Akers long to tease a giggle out of Gabriel Hagood on Wednesday, even though hours earlier the toddler had a valve closed in his heart by surgeons. Making sick, scared kids smile isn’t exactly in Akers’ job description at Memorial Hospital. But he certainly believes it is.

Viropro signs US $ 27 million MoU with BioChallenge PharmaBiz Mon, 19 Jun 2006 0:47 AM PDT Viropro Inc. has announced the signing of a Memorandum of Understanding (MoU) with BioChallenge, a privately-held pharmaceutical company operating in Tunis. This binding MoU aims at working jointly at the development and the production of several therapeutic proteins.

Central nervous system can sometimes send out signals that invite hostile immune system attacks News-Medical-Net Sun, 18 Jun 2006 1:48 PM PDT It may sound like a case of blame the victim, but researchers at Washington University School of Medicine in St. Louis have shown that cells in the central nervous system can sometimes send out signals that invite hostile immune system attacks.

Cabinet to keep bans on therapy cloning The Sunday Mail Sun, 18 Jun 2006 4:45 PM PDT A CONSERVATIVE backlash against stem cell research using surplus IVF embryos is expected to ensure federal Cabinet today retains bans on therapeutic cloning.

Virtual environments enable real recovery BioMechanics Sun, 18 Jun 2006 1:02 PM PDT The possibility of relearning motor control without risk of further injury may bring new hope to neurologic patients.